Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Debt to Equity (2016 - 2025)

Dare Bioscience's Debt to Equity history spans 8 years, with the latest figure at $0.0 for Q3 2025.

  • For Q3 2025, Debt to Equity changed N/A year-over-year to $0.0; the TTM value through Sep 2025 reached $0.0, changed N/A, while the annual FY2024 figure was -$0.0, N/A changed from the prior year.
  • Debt to Equity reached $0.0 in Q3 2025 per DARE's latest filing, up from -$0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.31 in Q1 2021 to a low of -$0.01 in Q2 2025.
  • Average Debt to Equity over 3 years is $0.07, with a median of $0.0 recorded in 2024.